Amgen

Omnicare reaches $4 million settlement over charges of receiving kickbacks for putting SNF residents on Aranesp

By

Omnicare, the nation's largest long-term care pharmacy, has reached a $4 million settlement agreement over allegations that the company conspired with a pharmaceutical company to switch nursing home residents to the anemia drug Aranesp, the U.S. Department of Justice announced Friday.

Amgen pays $25 million to settle whistleblower case over kickbacks to long-term care pharmacies

By

Biotechnology company Amgen will pay $24.9 million in a settlement over whistleblower allegations that the company paid kickbacks to long-term care pharmacies to increase the use of an anemia drug in nursing homes.

Amgen pleads guilty in False Claims Act case

Amgen "marketed the spread" between the price practices pay for Aranesp and that patients pay as a means of driving sales — to the point of having speakers tell physicians that they could make a million more each year by prescribing the Amgen anemia drug over its competitor, Procrit.